Perioperative medicine & outcomes
Regional Anesthesia for Outpatient Subcutaneous Implantable Cardioverter-Defibrillator Implantation:A 5-Year Retrospective Study
Main findingResult — go to the resultAdjusted odds ratio 3.27 95% CI 1.07–9.73Authors' conclusion
In outpatient S-ICD implantation, RA was associated with a higher likelihood of same-day discharge, lower periprocedural opioid requirements, reduced intraprocedural vasopressor use, and less HR variability.
Study context
- Population
- Outpatients undergoing subcutaneous implantable cardioverter-defibrillator (S-ICD) implantation, two quaternary-care academic centres, January 2020 to December 2024
- Participants
- 143 outpatients
- Exposure
- Regional anesthesia (RA) vs no RA for outpatient S-ICD implantation
- RAn = 63
- No RAn = 80reference
Methodological detailstwo-centre, multivariable logistic regression
- Two-centre
- Multivariable logistic regression
Main finding
As reported in the abstract
Adjusted odds ratio
3.27
95% CI 1.07–9.73
Events by group
Observational data: associations, not effects.
Further findings
Airway interventions (SGA or endotracheal intubation)
P < 0.001
Intraprocedural HR variability (max − min intraoperative HR)
P < 0.001
MAP variability (max − min intraoperative MAP)
P = 0.07
Recovery time
P = 0.016
Postoperative opioid requirements
P = 0.003
Events
| Outcome | RA | No RA | P value |
|---|---|---|---|
| Vasopressor administration | 34 | 71 | P < 0.001 |
Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.
Original publication
Composed by AI from the published abstract and checked against it. How Briefs are made →